Nate Chin
speaker
95 appearances
1 recordings
1 series
first heard Aug 2023
last heard Aug 2023
Nate Chin’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsNo recordings in the last 12 months.Older appearances are listed below; set an alert to hear about the next one.
Appearances
Yeah, Nate, you're gonna take the
No, no, I'm I I too will be a prescriber.
And I think what Sharon said is really important, shared decision making and making sure we find the right population, because not everyone is going to be right for this drug.
And certainly geriatricians, I think, will be experts in being able to discern who is the right person, when is the risk benefit ratio in the right direction.
Um, but I s
But I too, I mean, I think the science and the data really are there to prove that not only does it lower the amyloid and make it to the point where it's not present, but then there was a roughly, you know, Eric, a four month stability or delay.
In progression over an 18-month period.
And that could extend beyond 18 months.
We just don't know that.
But all of this has to be.
you know, understood by the patient and the families and and so that they're comfortable with that.
Certainly some people, it's just not gonna make sense.
Well, who are the right people, Nate?
Well, so that this is where I think staging is so important and often overlooked.
You know, this these drugs are indicated for people with mild cognitive impairment.
So those who are having symptoms, changes on cognitive tests, but not functionally impaired.
They can have
subtle changes, or I'm sure Jason will have a comment about that.
But they're so they're they're actually doing really well and they're very capable.
And so if they had pure Alzheimer's disease, truly just amyloid and maybe tau in their brain or low levels of Tau.
Showing 1–20 of 95 · page 1 of 5
Next →